ArticleCureus2025
Enhanced Predictive Accuracy of the Modified DECAF Score Over Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Chronic Obstructive Pulmonary Disease Exacerbations: A Comparative Study of Mortality and Hospital Stay Duration.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Predictive value of admission levels of IL-6 and PCT combined with the peri-treatment change in NLR (ΔNLR) for hospital length of stay in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).American journal of translational research · 2026Article
- The Role of Advanced Lung Cancer Inflammation Index in Predicting COPD Exacerbation Risks.International journal of chronic obstructive pulmonary disease · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic obstructive pulmonary disease (COPD) exacerbations contribute significantly to increased morbidity, mortality, and healthcare costs, necessitating effective predictive tools for patient outcomes. The modified DECAF score (baseline dyspnea, eosinopenia, consolidation, acidemia, and frequency of hospitalization in the last year), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) are commonly evaluated for their predictive accuracy in COPD exacerbations.
objectiveThis study aimed to compare the predictive accuracy of the modified DECAF score, NLR, and PLR in determining mortality and duration of hospital stay in patients with COPD exacerbations.
methodsA prospective cohort study was conducted on 100 patients hospitalized with COPD exacerbations. Data on demographics, clinical history, and laboratory parameters were collected. The predictive performance of the modified DECAF score, NLR, and PLR was assessed using statistical analyses, including sensitivity, specificity, and multivariate regression.
resultsThe modified DECAF score was significantly correlated with mortality (p < 0.01) and demonstrated superior predictive accuracy compared to NLR and PLR. While longer hospital stays were associated with higher modified DECAF scores, the correlations with NLR and PLR were not statistically significant. Environmental risk factors did not significantly impact mortality or the modified DECAF score.
conclusionThe modified DECAF score is a more reliable predictor of mortality and hospital stay duration in COPD exacerbations than NLR and PLR. Its implementation in clinical practice could enhance patient management by enabling better risk stratification. Further research is needed to validate these findings across diverse populations and explore the integration of genetic and epigenetic markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.